nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—EGFR—head and neck cancer	0.483	1	CbGaD
Lidocaine—EGFR—Docetaxel—head and neck cancer	0.173	0.43	CbGbCtD
Lidocaine—CYP2A6—Fluorouracil—head and neck cancer	0.0404	0.1	CbGbCtD
Lidocaine—CYP2D6—Hydroxyurea—head and neck cancer	0.0332	0.0827	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0211	0.0525	CbGbCtD
Lidocaine—CYP3A7—Docetaxel—head and neck cancer	0.0211	0.0525	CbGbCtD
Lidocaine—CYP2C8—Fluorouracil—head and neck cancer	0.0199	0.0495	CbGbCtD
Lidocaine—CYP3A5—Docetaxel—head and neck cancer	0.0158	0.0394	CbGbCtD
Lidocaine—CYP1A2—Fluorouracil—head and neck cancer	0.0154	0.0384	CbGbCtD
Lidocaine—CYP2C9—Fluorouracil—head and neck cancer	0.0139	0.0346	CbGbCtD
Lidocaine—ABCB1—Vinblastine—head and neck cancer	0.0125	0.0311	CbGbCtD
Lidocaine—CYP2D6—Vinblastine—head and neck cancer	0.0118	0.0293	CbGbCtD
Lidocaine—ABCB1—Docetaxel—head and neck cancer	0.0103	0.0256	CbGbCtD
Lidocaine—CYP3A4—Vinblastine—head and neck cancer	0.00748	0.0186	CbGbCtD
Lidocaine—CYP3A4—Docetaxel—head and neck cancer	0.00617	0.0153	CbGbCtD
Lidocaine—Papule—Hydroxyurea—head and neck cancer	0.00394	0.0713	CcSEcCtD
Lidocaine—Skin irritation—Fluorouracil—head and neck cancer	0.00143	0.0259	CcSEcCtD
Lidocaine—Slurred speech—Fluorouracil—head and neck cancer	0.00138	0.0251	CcSEcCtD
Lidocaine—Application site reaction—Fluorouracil—head and neck cancer	0.00132	0.0239	CcSEcCtD
Lidocaine—Blister—Hydroxyurea—head and neck cancer	0.00119	0.0216	CcSEcCtD
Lidocaine—Neurotoxicity—Docetaxel—head and neck cancer	0.00115	0.0209	CcSEcCtD
Lidocaine—Numbness—Vinblastine—head and neck cancer	0.00114	0.0206	CcSEcCtD
Lidocaine—Local reaction—Fluorouracil—head and neck cancer	0.00112	0.0202	CcSEcCtD
Lidocaine—Sensory loss—Vinblastine—head and neck cancer	0.00109	0.0197	CcSEcCtD
Lidocaine—Tenderness—Hydroxyurea—head and neck cancer	0.000985	0.0178	CcSEcCtD
Lidocaine—Blister—Fluorouracil—head and neck cancer	0.000858	0.0155	CcSEcCtD
Lidocaine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000821	0.0149	CcSEcCtD
Lidocaine—Numbness—Fluorouracil—head and neck cancer	0.000746	0.0135	CcSEcCtD
Lidocaine—Sensory loss—Fluorouracil—head and neck cancer	0.000714	0.0129	CcSEcCtD
Lidocaine—Tenderness—Fluorouracil—head and neck cancer	0.000709	0.0128	CcSEcCtD
Lidocaine—Disorientation—Hydroxyurea—head and neck cancer	0.000698	0.0126	CcSEcCtD
Lidocaine—Redness—Docetaxel—head and neck cancer	0.000662	0.012	CcSEcCtD
Lidocaine—Dysarthria—Fluorouracil—head and neck cancer	0.000654	0.0118	CcSEcCtD
Lidocaine—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.000653	0.0118	CcSEcCtD
Lidocaine—Burning sensation—Docetaxel—head and neck cancer	0.000643	0.0116	CcSEcCtD
Lidocaine—Throat sore—Docetaxel—head and neck cancer	0.00062	0.0112	CcSEcCtD
Lidocaine—Oropharyngeal discomfort—Docetaxel—head and neck cancer	0.000614	0.0111	CcSEcCtD
Lidocaine—Dermatitis contact—Fluorouracil—head and neck cancer	0.000612	0.0111	CcSEcCtD
Lidocaine—Coma—Fluorouracil—head and neck cancer	0.000565	0.0102	CcSEcCtD
Lidocaine—Euphoric mood—Fluorouracil—head and neck cancer	0.000532	0.00963	CcSEcCtD
Lidocaine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000517	0.00936	CcSEcCtD
Lidocaine—Disorientation—Fluorouracil—head and neck cancer	0.000502	0.00909	CcSEcCtD
Lidocaine—Oropharyngeal pain—Docetaxel—head and neck cancer	0.000491	0.00889	CcSEcCtD
Lidocaine—Drowsiness—Hydroxyurea—head and neck cancer	0.000481	0.00871	CcSEcCtD
Lidocaine—Haemoglobin—Vinblastine—head and neck cancer	0.000476	0.00861	CcSEcCtD
Lidocaine—Haemorrhage—Vinblastine—head and neck cancer	0.000473	0.00857	CcSEcCtD
Lidocaine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000471	0.00853	CcSEcCtD
Lidocaine—Hypoaesthesia—Vinblastine—head and neck cancer	0.000471	0.00853	CcSEcCtD
Lidocaine—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00047	0.00851	CcSEcCtD
Lidocaine—Stomatitis—Hydroxyurea—head and neck cancer	0.000469	0.00849	CcSEcCtD
Lidocaine—Osteoarthritis—Fluorouracil—head and neck cancer	0.000449	0.00813	CcSEcCtD
Lidocaine—Haemoglobin—Hydroxyurea—head and neck cancer	0.000434	0.00786	CcSEcCtD
Lidocaine—Haemorrhage—Hydroxyurea—head and neck cancer	0.000432	0.00782	CcSEcCtD
Lidocaine—Cardiac arrest—Fluorouracil—head and neck cancer	0.000427	0.00773	CcSEcCtD
Lidocaine—Skin exfoliation—Docetaxel—head and neck cancer	0.000426	0.00772	CcSEcCtD
Lidocaine—Neuropathy—Docetaxel—head and neck cancer	0.000419	0.00759	CcSEcCtD
Lidocaine—Lightheadedness—Docetaxel—head and neck cancer	0.0004	0.00723	CcSEcCtD
Lidocaine—Angiopathy—Hydroxyurea—head and neck cancer	0.000392	0.00709	CcSEcCtD
Lidocaine—Dysphagia—Fluorouracil—head and neck cancer	0.000388	0.00703	CcSEcCtD
Lidocaine—Chills—Hydroxyurea—head and neck cancer	0.000387	0.00701	CcSEcCtD
Lidocaine—Erythema—Hydroxyurea—head and neck cancer	0.000376	0.0068	CcSEcCtD
Lidocaine—Convulsion—Vinblastine—head and neck cancer	0.000357	0.00646	CcSEcCtD
Lidocaine—Hypertension—Vinblastine—head and neck cancer	0.000356	0.00644	CcSEcCtD
Lidocaine—Visual disturbance—Docetaxel—head and neck cancer	0.000342	0.00619	CcSEcCtD
Lidocaine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000339	0.00614	CcSEcCtD
Lidocaine—Dermatitis bullous—Docetaxel—head and neck cancer	0.000339	0.00614	CcSEcCtD
Lidocaine—Stomatitis—Fluorouracil—head and neck cancer	0.000337	0.00611	CcSEcCtD
Lidocaine—Convulsion—Hydroxyurea—head and neck cancer	0.000326	0.0059	CcSEcCtD
Lidocaine—Haemoglobin—Fluorouracil—head and neck cancer	0.000312	0.00565	CcSEcCtD
Lidocaine—Rhinitis—Fluorouracil—head and neck cancer	0.000312	0.00564	CcSEcCtD
Lidocaine—Haemorrhage—Fluorouracil—head and neck cancer	0.000311	0.00563	CcSEcCtD
Lidocaine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000309	0.0056	CcSEcCtD
Lidocaine—Oedema—Hydroxyurea—head and neck cancer	0.000307	0.00555	CcSEcCtD
Lidocaine—Paraesthesia—Vinblastine—head and neck cancer	0.000302	0.00547	CcSEcCtD
Lidocaine—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000301	0.00545	CcSEcCtD
Lidocaine—Pain—Vinblastine—head and neck cancer	0.000288	0.00521	CcSEcCtD
Lidocaine—Dysphagia—Docetaxel—head and neck cancer	0.00028	0.00507	CcSEcCtD
Lidocaine—Feeling abnormal—Vinblastine—head and neck cancer	0.000277	0.00502	CcSEcCtD
Lidocaine—Bronchospasm—Docetaxel—head and neck cancer	0.000276	0.00499	CcSEcCtD
Lidocaine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000273	0.00495	CcSEcCtD
Lidocaine—Somnolence—Hydroxyurea—head and neck cancer	0.000273	0.00494	CcSEcCtD
Lidocaine—Erythema—Fluorouracil—head and neck cancer	0.00027	0.0049	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000265	0.00479	CcSEcCtD
Lidocaine—Pain—Hydroxyurea—head and neck cancer	0.000262	0.00475	CcSEcCtD
Lidocaine—Vision blurred—Fluorouracil—head and neck cancer	0.000255	0.00462	CcSEcCtD
Lidocaine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000253	0.00458	CcSEcCtD
Lidocaine—Hypersensitivity—Vinblastine—head and neck cancer	0.000248	0.00449	CcSEcCtD
Lidocaine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000245	0.00443	CcSEcCtD
Lidocaine—Stomatitis—Docetaxel—head and neck cancer	0.000244	0.00441	CcSEcCtD
Lidocaine—Asthenia—Vinblastine—head and neck cancer	0.000241	0.00437	CcSEcCtD
Lidocaine—Convulsion—Fluorouracil—head and neck cancer	0.000234	0.00424	CcSEcCtD
Lidocaine—Chest pain—Fluorouracil—head and neck cancer	0.00023	0.00417	CcSEcCtD
Lidocaine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000226	0.00409	CcSEcCtD
Lidocaine—Haemoglobin—Docetaxel—head and neck cancer	0.000225	0.00408	CcSEcCtD
Lidocaine—Rhinitis—Docetaxel—head and neck cancer	0.000225	0.00407	CcSEcCtD
Lidocaine—Haemorrhage—Docetaxel—head and neck cancer	0.000224	0.00406	CcSEcCtD
Lidocaine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000223	0.00404	CcSEcCtD
Lidocaine—Confusional state—Fluorouracil—head and neck cancer	0.000223	0.00403	CcSEcCtD
Lidocaine—Dizziness—Vinblastine—head and neck cancer	0.000222	0.00403	CcSEcCtD
Lidocaine—Oedema—Fluorouracil—head and neck cancer	0.000221	0.004	CcSEcCtD
Lidocaine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000221	0.004	CcSEcCtD
Lidocaine—Asthenia—Hydroxyurea—head and neck cancer	0.00022	0.00398	CcSEcCtD
Lidocaine—Nervous system disorder—Fluorouracil—head and neck cancer	0.000216	0.00392	CcSEcCtD
Lidocaine—Visual impairment—Docetaxel—head and neck cancer	0.000216	0.00391	CcSEcCtD
Lidocaine—Vomiting—Vinblastine—head and neck cancer	0.000214	0.00387	CcSEcCtD
Lidocaine—Headache—Vinblastine—head and neck cancer	0.000211	0.00381	CcSEcCtD
Lidocaine—Eye disorder—Docetaxel—head and neck cancer	0.00021	0.00379	CcSEcCtD
Lidocaine—Cardiac disorder—Docetaxel—head and neck cancer	0.000208	0.00377	CcSEcCtD
Lidocaine—Flushing—Docetaxel—head and neck cancer	0.000208	0.00377	CcSEcCtD
Lidocaine—Hypotension—Fluorouracil—head and neck cancer	0.000206	0.00374	CcSEcCtD
Lidocaine—Angiopathy—Docetaxel—head and neck cancer	0.000203	0.00368	CcSEcCtD
Lidocaine—Dizziness—Hydroxyurea—head and neck cancer	0.000203	0.00367	CcSEcCtD
Lidocaine—Immune system disorder—Docetaxel—head and neck cancer	0.000203	0.00367	CcSEcCtD
Lidocaine—Chills—Docetaxel—head and neck cancer	0.000201	0.00364	CcSEcCtD
Lidocaine—Nausea—Vinblastine—head and neck cancer	0.0002	0.00362	CcSEcCtD
Lidocaine—Paraesthesia—Fluorouracil—head and neck cancer	0.000198	0.00359	CcSEcCtD
Lidocaine—Dyspnoea—Fluorouracil—head and neck cancer	0.000197	0.00356	CcSEcCtD
Lidocaine—Somnolence—Fluorouracil—head and neck cancer	0.000196	0.00355	CcSEcCtD
Lidocaine—Erythema—Docetaxel—head and neck cancer	0.000195	0.00353	CcSEcCtD
Lidocaine—Vomiting—Hydroxyurea—head and neck cancer	0.000195	0.00353	CcSEcCtD
Lidocaine—Rash—Hydroxyurea—head and neck cancer	0.000193	0.0035	CcSEcCtD
Lidocaine—Dermatitis—Hydroxyurea—head and neck cancer	0.000193	0.0035	CcSEcCtD
Lidocaine—Headache—Hydroxyurea—head and neck cancer	0.000192	0.00348	CcSEcCtD
Lidocaine—Dysgeusia—Docetaxel—head and neck cancer	0.000191	0.00346	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000191	0.00345	CcSEcCtD
Lidocaine—Back pain—Docetaxel—head and neck cancer	0.000189	0.00342	CcSEcCtD
Lidocaine—Pain—Fluorouracil—head and neck cancer	0.000189	0.00342	CcSEcCtD
Lidocaine—Nausea—Hydroxyurea—head and neck cancer	0.000182	0.0033	CcSEcCtD
Lidocaine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000182	0.00329	CcSEcCtD
Lidocaine—Urticaria—Fluorouracil—head and neck cancer	0.000175	0.00318	CcSEcCtD
Lidocaine—Loss of consciousness—Docetaxel—head and neck cancer	0.000172	0.00311	CcSEcCtD
Lidocaine—Convulsion—Docetaxel—head and neck cancer	0.000169	0.00306	CcSEcCtD
Lidocaine—Hypertension—Docetaxel—head and neck cancer	0.000169	0.00305	CcSEcCtD
Lidocaine—Chest pain—Docetaxel—head and neck cancer	0.000166	0.00301	CcSEcCtD
Lidocaine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000163	0.00294	CcSEcCtD
Lidocaine—Confusional state—Docetaxel—head and neck cancer	0.000161	0.00291	CcSEcCtD
Lidocaine—Oedema—Docetaxel—head and neck cancer	0.000159	0.00289	CcSEcCtD
Lidocaine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000159	0.00289	CcSEcCtD
Lidocaine—Shock—Docetaxel—head and neck cancer	0.000157	0.00284	CcSEcCtD
Lidocaine—Nervous system disorder—Docetaxel—head and neck cancer	0.000156	0.00283	CcSEcCtD
Lidocaine—Hypotension—Docetaxel—head and neck cancer	0.000149	0.0027	CcSEcCtD
Lidocaine—Dizziness—Fluorouracil—head and neck cancer	0.000146	0.00264	CcSEcCtD
Lidocaine—Paraesthesia—Docetaxel—head and neck cancer	0.000143	0.00259	CcSEcCtD
Lidocaine—Dyspnoea—Docetaxel—head and neck cancer	0.000142	0.00257	CcSEcCtD
Lidocaine—Somnolence—Docetaxel—head and neck cancer	0.000142	0.00256	CcSEcCtD
Lidocaine—Vomiting—Fluorouracil—head and neck cancer	0.00014	0.00254	CcSEcCtD
Lidocaine—Rash—Fluorouracil—head and neck cancer	0.000139	0.00252	CcSEcCtD
Lidocaine—Dermatitis—Fluorouracil—head and neck cancer	0.000139	0.00252	CcSEcCtD
Lidocaine—Headache—Fluorouracil—head and neck cancer	0.000138	0.0025	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000138	0.00249	CcSEcCtD
Lidocaine—Pain—Docetaxel—head and neck cancer	0.000136	0.00247	CcSEcCtD
Lidocaine—Feeling abnormal—Docetaxel—head and neck cancer	0.000131	0.00238	CcSEcCtD
Lidocaine—Nausea—Fluorouracil—head and neck cancer	0.000131	0.00237	CcSEcCtD
Lidocaine—Hypersensitivity—Docetaxel—head and neck cancer	0.000117	0.00213	CcSEcCtD
Lidocaine—Asthenia—Docetaxel—head and neck cancer	0.000114	0.00207	CcSEcCtD
Lidocaine—Dizziness—Docetaxel—head and neck cancer	0.000105	0.00191	CcSEcCtD
Lidocaine—Vomiting—Docetaxel—head and neck cancer	0.000101	0.00183	CcSEcCtD
Lidocaine—Rash—Docetaxel—head and neck cancer	0.0001	0.00182	CcSEcCtD
Lidocaine—Dermatitis—Docetaxel—head and neck cancer	0.0001	0.00182	CcSEcCtD
Lidocaine—Headache—Docetaxel—head and neck cancer	9.98e-05	0.00181	CcSEcCtD
Lidocaine—Nausea—Docetaxel—head and neck cancer	9.46e-05	0.00171	CcSEcCtD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—AKT1—head and neck cancer	2.4e-05	0.000403	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—HRAS—head and neck cancer	2.4e-05	0.000402	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—AKT1—head and neck cancer	2.39e-05	0.000401	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—HRAS—head and neck cancer	2.39e-05	0.000401	CbGpPWpGaD
Lidocaine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.38e-05	0.0004	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—AKT1—head and neck cancer	2.38e-05	0.000399	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—NAT2—head and neck cancer	2.38e-05	0.000398	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—STAT3—head and neck cancer	2.37e-05	0.000397	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—VEGFA—head and neck cancer	2.36e-05	0.000396	CbGpPWpGaD
Lidocaine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	2.35e-05	0.000394	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—HRAS—head and neck cancer	2.35e-05	0.000394	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	2.35e-05	0.000394	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	2.35e-05	0.000393	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—STAT3—head and neck cancer	2.34e-05	0.000392	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—AKT1—head and neck cancer	2.33e-05	0.000392	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—AKT1—head and neck cancer	2.31e-05	0.000387	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—DPYD—head and neck cancer	2.27e-05	0.000381	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GRP—head and neck cancer	2.27e-05	0.00038	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—MAPK3—head and neck cancer	2.26e-05	0.000379	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	2.25e-05	0.000377	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—AKT1—head and neck cancer	2.24e-05	0.000376	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—AKT1—head and neck cancer	2.24e-05	0.000376	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	2.24e-05	0.000376	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MAPK3—head and neck cancer	2.23e-05	0.000374	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.23e-05	0.000374	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—AKT1—head and neck cancer	2.22e-05	0.000372	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—AKT1—head and neck cancer	2.22e-05	0.000372	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—AKT1—head and neck cancer	2.22e-05	0.000372	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STAT6—head and neck cancer	2.2e-05	0.000369	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—AKT1—head and neck cancer	2.2e-05	0.000369	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—AKT1—head and neck cancer	2.19e-05	0.000367	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	2.17e-05	0.000364	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—VEGFA—head and neck cancer	2.16e-05	0.000363	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—YAP1—head and neck cancer	2.16e-05	0.000362	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—MAPK1—head and neck cancer	2.15e-05	0.000361	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—AKT1—head and neck cancer	2.14e-05	0.000359	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—CASP8—head and neck cancer	2.12e-05	0.000356	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—MAPK1—head and neck cancer	2.12e-05	0.000356	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—EGFR—head and neck cancer	2.12e-05	0.000356	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.12e-05	0.000355	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—AKT1—head and neck cancer	2.12e-05	0.000355	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.11e-05	0.000354	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	2.11e-05	0.000353	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—UROD—head and neck cancer	2.1e-05	0.000352	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—DPYD—head and neck cancer	2.08e-05	0.000349	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—AKT1—head and neck cancer	2.07e-05	0.000348	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MAPK3—head and neck cancer	2.05e-05	0.000343	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—CDH1—head and neck cancer	2.02e-05	0.000338	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	1.98e-05	0.000333	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—YAP1—head and neck cancer	1.98e-05	0.000331	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—YAP1—head and neck cancer	1.95e-05	0.000327	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—MAPK1—head and neck cancer	1.95e-05	0.000327	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—TYMS—head and neck cancer	1.95e-05	0.000327	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GSTM1—head and neck cancer	1.92e-05	0.000323	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—NAT2—head and neck cancer	1.92e-05	0.000321	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	1.91e-05	0.000321	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—NAT2—head and neck cancer	1.87e-05	0.000314	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—PIK3CA—head and neck cancer	1.87e-05	0.000313	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	1.85e-05	0.00031	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GPX1—head and neck cancer	1.84e-05	0.000309	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—CYP1A1—head and neck cancer	1.82e-05	0.000306	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—BCL2—head and neck cancer	1.82e-05	0.000306	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—HRAS—head and neck cancer	1.73e-05	0.00029	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.72e-05	0.000289	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.71e-05	0.000286	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HRAS—head and neck cancer	1.7e-05	0.000286	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—DPYD—head and neck cancer	1.68e-05	0.000282	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	1.67e-05	0.00028	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—DPYD—head and neck cancer	1.64e-05	0.000275	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—NAT2—head and neck cancer	1.62e-05	0.000272	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—YAP1—head and neck cancer	1.59e-05	0.000267	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.58e-05	0.000264	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—HRAS—head and neck cancer	1.56e-05	0.000262	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—YAP1—head and neck cancer	1.56e-05	0.000261	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—VEGFA—head and neck cancer	1.54e-05	0.000259	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—STAT3—head and neck cancer	1.53e-05	0.000256	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—AKT1—head and neck cancer	1.53e-05	0.000256	CbGpPWpGaD
Lidocaine—EGFR—Immune System—BCL2L1—head and neck cancer	1.51e-05	0.000254	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PTEN—head and neck cancer	1.51e-05	0.000253	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—AKT1—head and neck cancer	1.5e-05	0.000252	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.5e-05	0.000252	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.5e-05	0.000252	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MAPK3—head and neck cancer	1.46e-05	0.000245	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PTEN—head and neck cancer	1.45e-05	0.000243	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—DPYD—head and neck cancer	1.42e-05	0.000239	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—NAT2—head and neck cancer	1.41e-05	0.000237	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.4e-05	0.000235	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MAPK1—head and neck cancer	1.39e-05	0.000233	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.39e-05	0.000233	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—YAP1—head and neck cancer	1.35e-05	0.000226	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NAT2—head and neck cancer	1.33e-05	0.000223	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NAT2—head and neck cancer	1.32e-05	0.000221	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.3e-05	0.000218	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—TYMS—head and neck cancer	1.29e-05	0.000217	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—MAPK3—head and neck cancer	1.29e-05	0.000216	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.28e-05	0.000215	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.26e-05	0.000211	CbGpPWpGaD
Lidocaine—EGFR—Disease—NOTCH1—head and neck cancer	1.25e-05	0.00021	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—DPYD—head and neck cancer	1.24e-05	0.000208	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CASP8—head and neck cancer	1.24e-05	0.000207	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—MAPK1—head and neck cancer	1.23e-05	0.000206	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GPX1—head and neck cancer	1.23e-05	0.000206	CbGpPWpGaD
Lidocaine—EGFR—Immune System—CDH1—head and neck cancer	1.22e-05	0.000205	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—CYP1A1—head and neck cancer	1.21e-05	0.000203	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.2e-05	0.000201	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—TYMS—head and neck cancer	1.19e-05	0.000199	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.19e-05	0.000199	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—YAP1—head and neck cancer	1.18e-05	0.000197	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GSTM1—head and neck cancer	1.17e-05	0.000197	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—DPYD—head and neck cancer	1.17e-05	0.000196	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—DPYD—head and neck cancer	1.16e-05	0.000194	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NAT2—head and neck cancer	1.13e-05	0.000189	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GPX1—head and neck cancer	1.12e-05	0.000188	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HRAS—head and neck cancer	1.12e-05	0.000187	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—CYP1A1—head and neck cancer	1.11e-05	0.000186	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—YAP1—head and neck cancer	1.11e-05	0.000186	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—YAP1—head and neck cancer	1.1e-05	0.000184	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTGS2—head and neck cancer	1.09e-05	0.000182	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PIK3CA—head and neck cancer	1.07e-05	0.000179	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.06e-05	0.000178	CbGpPWpGaD
Lidocaine—EGFR—Immune System—BCL2—head and neck cancer	1.06e-05	0.000178	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—IL2—head and neck cancer	1.02e-05	0.000172	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PIK3CA—head and neck cancer	1.02e-05	0.000172	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.01e-05	0.00017	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—DPYD—head and neck cancer	9.89e-06	0.000166	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—HRAS—head and neck cancer	9.85e-06	0.000165	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—AKT1—head and neck cancer	9.85e-06	0.000165	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—TYMS—head and neck cancer	9.57e-06	0.000161	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GSTM1—head and neck cancer	9.46e-06	0.000159	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PTEN—head and neck cancer	9.46e-06	0.000159	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HRAS—head and neck cancer	9.46e-06	0.000159	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—YAP1—head and neck cancer	9.39e-06	0.000157	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—TYMS—head and neck cancer	9.36e-06	0.000157	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IL2—head and neck cancer	9.35e-06	0.000157	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTGS2—head and neck cancer	9.31e-06	0.000156	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GSTM1—head and neck cancer	9.25e-06	0.000155	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GPX1—head and neck cancer	9.06e-06	0.000152	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—CYP1A1—head and neck cancer	8.97e-06	0.00015	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GPX1—head and neck cancer	8.86e-06	0.000149	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.85e-06	0.000148	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PTEN—head and neck cancer	8.79e-06	0.000147	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NOTCH1—head and neck cancer	8.78e-06	0.000147	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	8.77e-06	0.000147	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NAT2—head and neck cancer	8.71e-06	0.000146	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—AKT1—head and neck cancer	8.7e-06	0.000146	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—AKT1—head and neck cancer	8.36e-06	0.00014	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.26e-06	0.000138	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—MAPK3—head and neck cancer	8.22e-06	0.000138	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTEN—head and neck cancer	8.12e-06	0.000136	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—TYMS—head and neck cancer	8.11e-06	0.000136	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GSTM1—head and neck cancer	8.01e-06	0.000134	CbGpPWpGaD
Lidocaine—EGFR—Immune System—STAT3—head and neck cancer	7.86e-06	0.000132	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—MAPK1—head and neck cancer	7.82e-06	0.000131	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GPX1—head and neck cancer	7.67e-06	0.000129	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—DPYD—head and neck cancer	7.64e-06	0.000128	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—CYP1A1—head and neck cancer	7.6e-06	0.000127	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MAPK3—head and neck cancer	7.51e-06	0.000126	CbGpPWpGaD
Lidocaine—EGFR—Disease—STAT3—head and neck cancer	7.26e-06	0.000122	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—YAP1—head and neck cancer	7.25e-06	0.000122	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTGS2—head and neck cancer	7.21e-06	0.000121	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.2e-06	0.000121	CbGpPWpGaD
Lidocaine—EGFR—Immune System—MAPK1—head and neck cancer	7.15e-06	0.00012	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—TYMS—head and neck cancer	7.06e-06	0.000118	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.05e-06	0.000118	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GSTM1—head and neck cancer	6.98e-06	0.000117	CbGpPWpGaD
Lidocaine—EGFR—Disease—MAPK3—head and neck cancer	6.94e-06	0.000116	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PIK3CA—head and neck cancer	6.79e-06	0.000114	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GPX1—head and neck cancer	6.68e-06	0.000112	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—PIK3CA—head and neck cancer	6.68e-06	0.000112	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—TYMS—head and neck cancer	6.65e-06	0.000112	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—CYP1A1—head and neck cancer	6.62e-06	0.000111	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTGS2—head and neck cancer	6.61e-06	0.000111	CbGpPWpGaD
Lidocaine—EGFR—Disease—MAPK1—head and neck cancer	6.6e-06	0.000111	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—TYMS—head and neck cancer	6.6e-06	0.000111	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GSTM1—head and neck cancer	6.58e-06	0.00011	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GSTM1—head and neck cancer	6.52e-06	0.000109	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GPX1—head and neck cancer	6.3e-06	0.000106	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PTEN—head and neck cancer	6.29e-06	0.000106	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—head and neck cancer	6.28e-06	0.000105	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GPX1—head and neck cancer	6.24e-06	0.000105	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.24e-06	0.000105	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	6.24e-06	0.000105	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PIK3CA—head and neck cancer	6.2e-06	0.000104	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—CYP1A1—head and neck cancer	6.18e-06	0.000104	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.15e-06	0.000103	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—IL2—head and neck cancer	6.04e-06	0.000101	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CCND1—head and neck cancer	5.89e-06	9.88e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PTEN—head and neck cancer	5.77e-06	9.67e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—head and neck cancer	5.74e-06	9.63e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—PIK3CA—head and neck cancer	5.73e-06	9.61e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTEN—head and neck cancer	5.69e-06	9.54e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—TYMS—head and neck cancer	5.64e-06	9.45e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GSTM1—head and neck cancer	5.57e-06	9.35e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—head and neck cancer	5.55e-06	9.3e-05	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—head and neck cancer	5.45e-06	9.15e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GPX1—head and neck cancer	5.34e-06	8.95e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTGS2—head and neck cancer	5.34e-06	8.95e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—head and neck cancer	5.3e-06	8.89e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	5.28e-06	8.86e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTGS2—head and neck cancer	5.22e-06	8.75e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VEGFA—head and neck cancer	5.14e-06	8.61e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—STAT3—head and neck cancer	5.08e-06	8.53e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.08e-06	8.52e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—head and neck cancer	5.07e-06	8.5e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAPK3—head and neck cancer	4.86e-06	8.15e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—head and neck cancer	4.68e-06	7.85e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PTEN—head and neck cancer	4.65e-06	7.8e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MAPK1—head and neck cancer	4.62e-06	7.75e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PTEN—head and neck cancer	4.55e-06	7.63e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTGS2—head and neck cancer	4.52e-06	7.58e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—PIK3CA—head and neck cancer	4.44e-06	7.44e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—TYMS—head and neck cancer	4.35e-06	7.3e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.34e-06	7.28e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.3e-06	7.21e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GPX1—head and neck cancer	4.12e-06	6.91e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.08e-06	6.84e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—PIK3CA—head and neck cancer	4.07e-06	6.82e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PIK3CA—head and neck cancer	4.01e-06	6.73e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PTEN—head and neck cancer	3.94e-06	6.61e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTGS2—head and neck cancer	3.94e-06	6.6e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—head and neck cancer	3.88e-06	6.51e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—head and neck cancer	3.71e-06	6.22e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTGS2—head and neck cancer	3.71e-06	6.22e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.68e-06	6.17e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—head and neck cancer	3.63e-06	6.08e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PTEN—head and neck cancer	3.43e-06	5.76e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—head and neck cancer	3.32e-06	5.57e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	3.28e-06	5.51e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—head and neck cancer	3.28e-06	5.5e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PTEN—head and neck cancer	3.23e-06	5.42e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	3.21e-06	5.38e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PTEN—head and neck cancer	3.21e-06	5.38e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTGS2—head and neck cancer	3.14e-06	5.27e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.78e-06	4.66e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PTEN—head and neck cancer	2.74e-06	4.59e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—head and neck cancer	2.68e-06	4.5e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—head and neck cancer	2.62e-06	4.4e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.42e-06	4.07e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.42e-06	4.06e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	2.28e-06	3.83e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—head and neck cancer	2.27e-06	3.81e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	2.26e-06	3.79e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PTEN—head and neck cancer	2.11e-06	3.55e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—head and neck cancer	1.98e-06	3.32e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.93e-06	3.24e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—head and neck cancer	1.86e-06	3.13e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—head and neck cancer	1.85e-06	3.1e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—head and neck cancer	1.58e-06	2.65e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.49e-06	2.5e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—head and neck cancer	1.22e-06	2.04e-05	CbGpPWpGaD
